FTO and lung adenocarcinoma: To determine the role of FTO in lung adenocarcinoma progression, we depleted FTO expression in H322 (Fig. 1F) and H358 (Fig. S1A) lung adenocarcinoma cells with two different shRNAs (shFTO-1 and shFTO-2).